Thomas Gajewski to Infusions, Intravenous
This is a "connection" page, showing publications Thomas Gajewski has written about Infusions, Intravenous.
Connection Strength
0.043
-
Combination of vemurafenib and cobimetinib in patients with advanced BRAF(V600)-mutated melanoma: a phase 1b study. Lancet Oncol. 2014 Aug; 15(9):954-65.
Score: 0.025
-
Phase I/II trial of tremelimumab in patients with metastatic melanoma. J Clin Oncol. 2009 Mar 01; 27(7):1075-81.
Score: 0.017